Condition
Lung Cancer Stage III clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Lung Cancer Stage III clinical trials that are recruiting, at sites in 5 countries (most in China (3), United States (1), France (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Lung Cancer Stage III clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using bioabsorbable staples to improve surgery outcomes for rectal and lung cancer | Phase 3 | Shanghai | Recruiting | May 13, 2025 |
| Targeted therapy for patients with unresectable stage III lung cancer and rare mutations | Phase 2 | Guangzhou, Guangdong | Recruiting | Aug 21, 2024 |
| Evaluating ctDNA diagnostics for Stage III lung cancer | — | Nice, Nice and 5 other locations | Recruiting | Nov 1, 2023 |
| Combining Certolizumab with Chemotherapy and Nivolumab for Treating Lung Cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Aug 5, 2021 |
| Treatment for unresectable stage III non-small cell lung cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | Mar 13, 2019 |
All recruiting trials (5)
-
Using bioabsorbable staples to improve surgery outcomes for rectal and lung cancer
This study is testing if using special dissolvable staples during stomach, colorectal, and lung surgeries can help patients have fewer complications after their operations compared to regular staples.
-
Targeted therapy for patients with unresectable stage III lung cancer and rare mutations
This study is testing if targeted therapies for rare mutations can help patients with advanced lung cancer who can't have surgery and haven't been treated before.
-
Evaluating ctDNA diagnostics for Stage III lung cancer
This study is testing how well blood tests that check for tumor DNA can help people with Stage III lung cancer during and after their treatment.
-
Combining Certolizumab with Chemotherapy and Nivolumab for Treating Lung Cancer
This study is testing if adding certolizumab to regular chemotherapy and nivolumab can help people with operable stage II-III lung cancer feel better by reducing inflammation and improving treatment results.
-
Treatment for unresectable stage III non-small cell lung cancer
This study is testing a new combination treatment for people with stage III non-small cell lung cancer that can't be surgically removed, to see if it works better than the usual options before surgery.
Related topics
Quick answers
How many Lung Cancer Stage III clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (3 trials), United States (1 trial), France (1 trial), Germany (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.